X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-02 | EWTX | Russell Alan J | Chief Scientific Officer | S - Sale+OE | $16.45 | -1,551 | 18,521 | -8% | -$25,520 | |||||
| D | 2025-05-02 | EWTX | Moore John R | GC | S - Sale+OE | $16.45 | -1,930 | 6,531 | -23% | -$31,757 | |||||
| D | 2025-05-02 | EWTX | Koch Kevin | Pres, CEO | S - Sale+OE | $16.45 | -4,276 | 385,813 | -1% | -$70,358 | |||||
| D | 2025-05-02 | EWTX | Donovan Joanne M. | CMO | S - Sale+OE | $16.45 | -5,187 | 21,588 | -19% | -$85,348 | |||||
| D | 2025-05-02 | EWTX | Derakhshan Behrad | Chief Business Officer | S - Sale+OE | $16.45 | -1,691 | 20,355 | -8% | -$27,824 | |||||
| D | 2025-05-02 | EWTX | Carruthers R Michael | CFO | S - Sale+OE | $16.45 | -1,314 | 81,014 | -2% | -$21,621 | |||||
2025-04-03 | EWTX | Thompson Peter A. | Dir, 10% | P - Purchase | $20.13 | +496,771 | 443,792 | -938% | +$10,000,000 | ||||||
2025-04-03 | EWTX | Orbimed Advisors LLC | Dir, 10% | P - Purchase | $20.13 | +496,771 | 443,792 | -938% | +$10,000,000 | ||||||
| D | 2025-03-07 | EWTX | Russell Alan J | Chief Scientific Officer | S - Sale+OE | $30.02 | -200 | 14,863 | -1% | -$6,004 | |||||
| D | 2025-03-07 | EWTX | Koch Kevin | Pres, CEO | S - Sale+OE | $30.00 | -100 | 353,262 | 0% | -$3,000 | |||||
| DM | 2025-02-05 | EWTX | Russell Alan J | Chief Scientific Officer | S - Sale+OE | $30.04 | -9,215 | 14,863 | -38% | -$276,776 | |||||
| DM | 2025-02-05 | EWTX | Koch Kevin | Pres, CEO | S - Sale+OE | $30.13 | -9,536 | 353,262 | -3% | -$287,316 | |||||
| D | 2025-02-05 | EWTX | Derakhshan Behrad | Chief Business Officer | S - Sale+OE | $30.03 | -10,000 | 16,837 | -37% | -$300,300 | |||||
| D | 2025-01-28 | EWTX | Donovan Joanne M. | CMO | S - Sale+OE | $27.63 | -25,000 | 16,358 | -60% | -$690,658 | |||||
| D | 2024-12-30 | EWTX | Russell Alan J | Chief Scientific Officer | S - Sale+OE | $27.37 | -100,000 | 14,863 | -87% | -$2,737,470 | |||||
| D | 2024-12-24 | EWTX | Semigran Marc | Chief Development Officer | S - Sale+OE | $29.69 | -29,709 | 6,716 | -82% | -$881,915 | |||||
| D | 2024-09-20 | EWTX | Russell Alan J | Chief Scientific Officer | S - Sale+OE | $28.27 | -75,000 | 12,719 | -86% | -$2,120,101 | |||||
| DM | 2024-09-20 | EWTX | Moore John R | GC | S - Sale+OE | $28.15 | -70,922 | 3,252 | -96% | -$1,996,574 | |||||
2024-09-20 | EWTX | Donovan Joanne M. | CMO | S - Sale | $28.29 | -7,162 | 14,538 | -33% | -$202,603 | ||||||
| D | 2024-09-20 | EWTX | Derakhshan Behrad | Chief Business Officer | S - Sale+OE | $29.03 | -42,068 | 15,121 | -74% | -$1,221,133 | |||||
| D | 2024-09-20 | EWTX | Carruthers R Michael | CFO | S - Sale+OE | $28.57 | -125,092 | 6,904 | -95% | -$3,573,980 | |||||
| D | 2024-05-02 | EWTX | Moore John R | GC | S - Sale+OE | $18.91 | -1,956 | 3,252 | -38% | -$36,988 | |||||
| D | 2024-05-02 | EWTX | Carruthers R Michael | CFO | S - Sale+OE | $18.91 | -2,157 | 35,230 | -6% | -$40,789 | |||||
| D | 2024-05-02 | EWTX | Derakhshan Behrad | Chief Business Officer | S - Sale+OE | $18.91 | -1,718 | 13,422 | -11% | -$32,487 | |||||
| D | 2024-05-02 | EWTX | Russell Alan J | Chief Scientific Officer | S - Sale+OE | $18.91 | -1,576 | 7,238 | -18% | -$29,802 | |||||
| D | 2024-05-02 | EWTX | Donovan Joanne M. | CMO | S - Sale+OE | $18.91 | -3,682 | 19,897 | -16% | -$69,627 | |||||
| D | 2024-05-02 | EWTX | Koch Kevin | Pres, CEO | S - Sale+OE | $18.91 | -3,152 | 353,262 | -1% | -$59,604 | |||||
| DM | 2024-02-07 | EWTX | Moore John R | GC | S - Sale+OE | $20.00 | -29,835 | 0 | -100% | -$596,805 | |||||
| DM | 2024-02-07 | EWTX | Derakhshan Behrad | Chief Business Officer | S - Sale+OE | $20.03 | -10,000 | 7,020 | -59% | -$200,258 | |||||
| D | 2024-01-23 | EWTX | Carruthers R Michael | CFO | S - Sale+OE | $15.78 | -90,000 | 29,024 | -76% | -$1,419,759 | |||||
2024-01-23 | EWTX | Thompson Peter A. | Dir, 10% | P - Purchase | $11.00 | +454,545 | 14,756,096 | +3% | +$4,999,995 | ||||||
2024-01-23 | EWTX | Orbimed Advisors LLC | Dir, 10% | P - Purchase | $11.00 | +454,545 | 14,756,096 | +3% | +$4,999,995 | ||||||
2023-12-26 | EWTX | Fox Jonathan C | Dir | P - Purchase | $9.30 | +10,857 | 10,857 | New | +$100,958 | ||||||
2023-12-27 | EWTX | Moore John R | GC | S - Sale | $10.50 | -8,497 | 0 | -100% | -$89,219 | ||||||
2023-12-26 | EWTX | Russell Alan J | Chief Scientific Officer | S - Sale | $9.33 | -172,585 | 3,606 | -98% | -$1,610,097 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |